Novel Compositions and Methods for Promoting, Inhibiting and Detecting Protein Entry Into Cells
AssigneeBoston Medical Center Corporation
InventorsJohn R. Murphy, Ryan Ratts
Life of this patent
Estimating the term…
Abstract
The invention features methods for identifying compounds that inhibit cell death, and methods for identifying compounds that promote cell death, by blocking or accelerating, respectively, the translocation of the catalytic domain of toxins or transcription factors through the endosomal membrane into the cytosol of a cell. Also featured are methods for inhibiting cell death that include the administration of polypeptides that include a toxin consensus sequence recognized by one or more components of the cytosolic translocation factor complex.
Claims44
A polypeptide comprising the sequence of formula I,
- AA215-AA216-AA217-AA218-AA219-AA220-AA221-AA222-AA223-AA224 (I),
- wherein AA215 is Thr, Ser, Gly, or Leu;
- AA216 is Glu, Arg, Gln, or Lys;
- AA217 is Lys, Ile, Glu, or Val;
- AA218 is Glu or Asp;
- AA219 is Lys, Glu, His, Leu, Arg, Asn, or Ser;
- AA220 is Phe, Leu, or Ile;
- AA221 is Lys or Arg;
- AA222 is Glu, Asn, Asp, or Lys;
- AA223 is Lys, His, Ser, Ile, or Asn;
- and AA224 is Gly, Leu, Val, Met, or Ile.
A method of identifying a compound that inhibits cell death in a mammal comprising the following steps:
- a) isolating, from a cell, intact endosomes comprising a toxin, wherein the endosomes are maintained in a neutral or basic pH;
- b) placing said endosomes in a cytosolic buffer;
- c) contacting said endosomes with one or more of α-COP, β-COP, β′-COP, γ-COP, δ-COP, ε-COP, ζ-COP, HSP-90, or TrR-1;
- d) contacting said endosomes with said compound;
- e) acidifying said endosomes;
- and
- f) measuring translocation of said toxin across a membrane of said endosomes, wherein a decreased level of said translocation relative to that observed in the absence of said compound indicates that said compound inhibits said cell death.
A method of identifying a compound that promotes cell death in a mammal comprising the following steps:
- a) isolating, from a cell, intact endosomes comprising a toxin, wherein the endosomes are maintained in a neutral or basic pH;
- b) placing said endosomes in a cytosolic buffer;
- c) contacting said endosomes with one or more of α-COP, β-COP, β′-COP, γ-COP, δ-COP, ε-COP, ζ-COP, HSP-90, or TrR-1;
- c) contacting said endosomes with said compound;
- d) acidifying said endosomes;
- and
- e) measuring translocation of said toxin, wherein an increased level of said translocation relative to that observed in the absence of said compound indicates that said compound promotes said cell death.
A method of inhibiting cell death in a mammal comprising administering to said mammal a polypeptide of formula I,
- AA215-AA216-AA217-AA218-AA219-AA220-AA221-AA222-AA223-AA224 (I),
- wherein AA215 is Thr, Ser, Gly, or Leu;
- AA216 is Glu, Arg, Gln, or Lys;
- AA217 is Lys, Ile, Glu, or Val;
- AA218 is Glu or Asp;
- AA219 is Lys, Glu, His, Leu, Arg, Asn, or Ser;
- AA220 is Phe, Leu, or Ile;
- AA221 is Lys or Arg;
- AA222 is Glu, Asn, Asp, or Lys;
- AA221 is Lys, His, Ser, Ile, or Asn;
- and AA224 is Gly, Leu, Val, Met, or Ile;
- wherein said polypeptide further comprises one or more KXKXX sequences;
- and
- wherein said polypeptide inhibits cell death in said mammal.
A method of inhibiting cell death in a mammal comprising administering to said mammal a nucleic acid sequence encoding a polypeptide having the sequence of formula I,
- AA215-AA216-AA217-AA218-AA219-AA220-AA221-AA222-AA223-AA224 (I),
- wherein AA215 is Thr, Ser, Gly, or Leu;
- AA216 is Glu, Arg, Gln, or Lys;
- AA217 is Lys, Ile, Glu, or Val;
- AA218 is Glu or Asp;
- AA219 is Lys, Glu, His, Leu, Arg, Asn, or Ser;
- AA220 is Phe, Leu, or Ile;
- AA221 is Lys or Arg;
- AA222 is Glu, Asn, Asp, or Lys;
- AA223 is Lys, His, Ser, Ile, or Asn;
- and AA224 is Gly, Leu, Val, Met, or Ile;
- wherein said nucleic acid further encodes one or more KXKXX sequences;
- and
- wherein said polypeptide inhibits cell death in said mammal.
Dependencies are inferred from the claim text.